Suppr超能文献

当代研究结果表明,再次冠状动脉旁路移植术仍是手术死亡率的一个危险因素。

Contemporary results show repeat coronary artery bypass grafting remains a risk factor for operative mortality.

作者信息

Yap Cheng-Hon, Sposato Luigi, Akowuah Enoch, Theodore Sanjay, Dinh Diem T, Shardey Gilbert C, Skillington Peter D, Tatoulis James, Yii Michael, Smith Julian A, Mohajeri Morteza, Pick Adrian, Seevanayagam Siven, Reid Christopher M

机构信息

Department of Epidemiology and Preventive Medicine, Monash University, Victoria, Australia.

出版信息

Ann Thorac Surg. 2009 May;87(5):1386-91. doi: 10.1016/j.athoracsur.2009.02.006.

Abstract

BACKGROUND

Reoperative coronary artery bypass grafting (redo CABG) shows improving outcomes, but with varying degrees of improvement. We assessed contemporary outcomes after redo CABG to determine if redo status is still a risk factor for early postoperative complications and midterm survival.

METHODS

Isolated CABG procedures (June 1, 2001 to May 31, 2008) within the Australasian Society of Cardiac and Thoracic Surgeons Cardiac Surgery Database were included. Redo status as a predictor for early outcomes was assessed with logistic regression analysis. Midterm survival was determined from the National Death Index. Effect of redo status on midterm survival was assessed using a Cox proportional hazards model.

RESULTS

Inclusion criteria were met by 13,436 patients, and 458 (3.4%) underwent redo CABG. Operative mortality was 4.8% for redo CABG and 1.8% for first-time CABG (p < 0.001). After adjustment, redo status remained a predictor for operative mortality (odds ratio [OR], 2.1; 95% confidence interval [CI], 1.3 to 3.6), myocardial infarction (OR, 2.8; 95% CI, 1.6 to 6.0), and prolonged ventilation (OR, 1.5; 95% CI, 1.1 to 2.0). Unadjusted survival was lower for the redo CABG group vs the first-time CABG group at up to 6 years (p = 0.01, log-rank test. After adjusting for differences in patient variables, redo status was not a predictor of midterm survival (OR, 1.03; 95% CI, 0.78 to 1.35; p = 0.85).

CONCLUSIONS

Early postoperative outcomes of redo CABG are encouraging. Midterm survival is excellent; however, redo remains a significant risk factor for operative mortality in contemporary practice.

摘要

背景

再次冠状动脉旁路移植术(redo CABG)的疗效有所改善,但改善程度各异。我们评估了redo CABG后的当代疗效,以确定再次手术状态是否仍是术后早期并发症和中期生存的危险因素。

方法

纳入澳大利亚和新西兰心脏与胸外科医师协会心脏手术数据库中2001年6月1日至2008年5月31日期间的单纯CABG手术。采用逻辑回归分析评估再次手术状态作为早期疗效预测指标的情况。从中期国家死亡指数确定中期生存率。使用Cox比例风险模型评估再次手术状态对中期生存的影响。

结果

13436例患者符合纳入标准,458例(3.4%)接受了redo CABG。redo CABG的手术死亡率为4.8%,初次CABG为1.8%(p<0.001)。调整后,再次手术状态仍是手术死亡率(比值比[OR],2.1;95%置信区间[CI],1.3至3.6)、心肌梗死(OR,2.8;95%CI,1.6至6.0)和通气时间延长(OR,1.5;95%CI,1.1至2.0)的预测指标。redo CABG组与初次CABG组相比,未调整的生存率在长达6年的时间里较低(p = 0.01,对数秩检验)。在调整患者变量差异后,再次手术状态不是中期生存的预测指标(OR,1.03;95%CI,0.78至1.35;p = 0.85)。

结论

redo CABG术后早期疗效令人鼓舞。中期生存率良好;然而,在当代实践中,再次手术仍是手术死亡率的重要危险因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验